Karen Hodgkin | Chief Operating Officer
Cell Medica Ltd

Karen Hodgkin, Chief Operating Officer, Cell Medica Ltd

Karen has over 30 years of experience in planning and running clinical trials, which has been invaluable in the creation of Cell Medica’s highly-efficient clinical operations and regulatory function. After working as SVP, Clinical Operations, Karen has moved to become Cell Medica’s COO in September 2016.

In the past, Karen has worked for Boehringer Ingelheim (UK), ICN Pharmaceuticals (UK) and British Biotech (UK/US) and as a clinical operations consultant in the US. Her experience spans a range of therapeutic applications and has been acquired whilst running single and multicenter studies globally.

Karen has a Diploma in Clinical Science from the University of Wales Institute of Science & Technology, an MSc in Bio pharmacy from King’s College London and a BSc in pharmacology from Leeds University in the UK.

Appearances:



15th May Pre-Conference Workshops and Summits Day @ 15:00

Clinical trial focus workshop: What needs to be done to get these experimental treatments to patients in the clinic?

· Centralized and decentralized models· Sourcing starting material: apheresis, tumor, bone marrow· From manufacture to back into local environment· Design of clinical trial
last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.